{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:05:37Z","timestamp":1783044337174,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"am","delay-in-days":288,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["R01DA047365"],"award-info":[{"award-number":["R01DA047365"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.josat.2023.209247","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T03:03:27Z","timestamp":1702004607000},"page":"209247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years"],"prefix":"10.1016","volume":"158","author":[{"given":"Amanda J.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney R.","family":"Yarbrough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.josat.2023.209247_bb0005","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1475-6773.13113","article-title":"County-level access to opioid use disorder medications in medicare Part D (2010\u20132015)","volume":"54","author":"Abraham","year":"2019","journal-title":"Health Services Research"},{"issue":"1","key":"10.1016\/j.josat.2023.209247_bb0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/1475-6773.12686","article-title":"Geographic disparities in availability of opioid use disorder treatment for Medicaid enrollees","volume":"53","author":"Abraham","year":"2018","journal-title":"Health Services Research"},{"issue":"2","key":"10.1016\/j.josat.2023.209247_bb0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/appi.ps.202000049","article-title":"Medicaid expansion and availability of opioid medications in the specialty substance use disorder treatment system","volume":"72","author":"Abraham","year":"2021","journal-title":"Psychiatric Services"},{"issue":"4","key":"10.1016\/j.josat.2023.209247_bb0020","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11414-013-9387-2","article-title":"The relationship of state Medicaid coverage to Medicaid acceptance among substance abuse providers in the United States","volume":"41","author":"Andrews","year":"2014","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"1","key":"10.1016\/j.josat.2023.209247_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1077558713503188","article-title":"Adoption of evidence-based clinical innovations: The case of buprenorphine use by opioid treatment programs","volume":"71","author":"Andrews","year":"2014","journal-title":"Medical Care Research and Review"},{"key":"10.1016\/j.josat.2023.209247_bb0030","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.josat.2023.209247_bb0035","author":"Centers for Medicare and Medicaid Services"},{"issue":"1","key":"10.1016\/j.josat.2023.209247_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13011-022-00478-y","article-title":"Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by Medicare in 2021","volume":"17","author":"Clemans-Cope","year":"2022","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"7","key":"10.1016\/j.josat.2023.209247_bb0045","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jama.288.7.850","article-title":"Changes in methadone treatment practices: Results from a national panel study, 1988\u20132000","volume":"288","author":"D\u2019Aunno","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2023.209247_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1747-597X-3-17","article-title":"State policy influence on the early diffusion of buprenorphine in community treatment programs","volume":"3","author":"Ducharme","year":"2008","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"5","key":"10.1016\/j.josat.2023.209247_bb0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amepre.2022.05.006","article-title":"Racial\u2013ethnic disparities of buprenorphine and vivitrol receipt in Medicaid","volume":"63","author":"Dunphy","year":"2022","journal-title":"American Journal of Preventive Medicine"},{"issue":"2","key":"10.1016\/j.josat.2023.209247_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1377\/hlthaff.2019.00309","article-title":"Gaps in access to opioid use disorder treatment for Medicare beneficiaries","volume":"39","author":"Harris","year":"2020","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"10.1016\/j.josat.2023.209247_bb0070","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1377\/hlthaff.2023.00148","article-title":"Changes in county-level access to medications for opioid use disorder after Medicare coverage of methadone treatment began","volume":"42","author":"Harris","year":"2023","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.josat.2023.209247_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107616","article-title":"Characteristics and current clinical practices of opioid treatment programs in the United States","volume":"205","author":"Jones","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2023.209247_bb0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamapsychiatry.2020.1511","article-title":"Methadone for opioid use disorder-decades of effectiveness but still miles away in the US","volume":"77","author":"Joudrey","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2023.209247_bb0085","series-title":"Tracking the quality of addiction treatment over time and across states: Using the federal government\u2019s \u201csigns\u201d of higher quality","author":"Mark","year":"2020"},{"key":"10.1016\/j.josat.2023.209247_bb0090","article-title":"Improving research on racial disparities in access to medications to treat opioid use disorders","author":"Mark","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209247_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42982","article-title":"Disparities by sex and race and ethnicity in death rates due to opioid overdose among adults 55 years or older, 1999 to 2019","volume":"5","author":"Mason","year":"2022","journal-title":"JAMA Network Open"},{"issue":"9","key":"10.1016\/j.josat.2023.209247_bb0100","article-title":"Opioid agonist treatment for people who are dependent on pharmaceutical opioids","author":"Nielsen","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2023.209247_bb0105","series-title":"Opioid overdoses and the limited treatment of opioid use disorder continue to be concerns for Medicare beneficiaires","author":"Office of Inspector General","year":"2022"},{"issue":"2","key":"10.1016\/j.josat.2023.209247_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amepre.2022.01.021","article-title":"Substance use disorders among Medicare beneficiaries: Prevalence, mental and physical comorbidities, and treatment barriers","volume":"63","author":"Parish","year":"2022","journal-title":"American Journal of Preventive Medicine"},{"issue":"6","key":"10.1016\/j.josat.2023.209247_bb0115","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.amepre.2021.01.010","article-title":"Trends in opioid use disorder among older adults: Analyzing Medicare data, 2013\u20132018","volume":"60","author":"Shoff","year":"2021","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.josat.2023.209247_bb0120","author":"Steinberg"},{"key":"10.1016\/j.josat.2023.209247_bb0125","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2023.209247_bb0130","unstructured":"SUPPORT for Patients and Communities Act. (2018)."}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:51:43Z","timestamp":1757433103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"alternative-id":["S2949875923002990"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209247","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209247"}}